One study revealed that in patients treated for GBM, Psp was present in 21 (91%) of the 23 patients with hypermethylation and in 11 (41%) of the 27 patients who received treatment with unmethylated MGMT promoter (p < 0.001). Here, MGMT is linked to glioblastoma.